Enterome starts development of new cancer drugs
Interviewee/Contributor
Jan Fagerberg
Organisation
Enterome SA
Research Directory
Mimicking anti-viral innate immunity against cancer
Interviewee/ContributorAlex Karlsson-Parra and Sijme ZeilemakerOrganisationImmunicum ABChristmas comes early for Europe's biotech stocks
Interviewee/ContributorWilliam EllingtonOrganisationMedNousIntegrated product development for ATMPs
Interviewee/ContributorClaes Buxfeldt and Paula SalmikangasOrganisationNDA Advisory Services LtdThe role of oncolytic viruses in immuno-oncology
Interviewee/ContributorBernard Huber and Paul HighamOrganisationOryx GmbH & Co KG and Valo Therapeutics LtdJ&J plans large Covid-19 vaccine trial
Interviewee/ContributorPeter CharlishOrganisationMedNousInvestors support new antifungal agent
Interviewee/ContributorRalf Schmid and Emma HarveyOrganisationF2G LtdCovid-19: still more questions than answers
Interviewee/ContributorPeter CharlishOrganisationMedNousEvox developes exosomes as therapeutics
Interviewee/ContributorAntonin de FougerollesOrganisationEvox Therapeutics LtdA new paradigm for cancer therapy emerges
Interviewee/ContributorVictoria EnglishOrganisationMedNous